Ls Investment Advisors, LLC Eagle Pharmaceuticals, Inc. Transaction History

Ls Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$37.02 - $51.28 $83,480 - $115,636	-2,255 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$54.32 - $64.31 $14,394 - $17,042	265 Added 13.32%	2,255 $135,000
Q2 2019 Aug 07, 2019	BUY	$46.61 - $58.45 $1,538 - $1,928	33 Added 1.69%	1,990 $111,000
Q1 2019 Apr 25, 2019	SELL	$38.66 - $51.82 $7,731 - $10,364	-200 Reduced 9.27%	1,957 $99,000
Q4 2018 Feb 01, 2019	BUY	$36.72 - $67.73 $39,180 - $72,267	1,067 Added 97.89%	2,157 $87,000
Q3 2018 Nov 13, 2018	SELL	$66.65 - $83.86 $13,130 - $16,520	-197 Reduced 15.31%	1,090 $76,000
Q4 2017 Feb 07, 2018	BUY	$49.6 - $60.87 $10,812 - $13,269	218 Added 20.39%	1,287 $69,000
Q3 2017 Oct 19, 2017	BUY	$46.62 - $60.36 $49,836 - $64,524	1,069	1,069 $64,000

8.59M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $9.24M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.